언어 선택

IFN-alpha 2b

IFN-alpha 2b 분자 정보

영어 이름	Interferon alpha-2	시판 약물 수	1
임상 약물 수	10	표적 별명	IFNA2B，IFNA2C，LeIF A，Interferon alpha-2，IFN-alpha-2，IFNA2，Interferon Alpha 2，Alpha-2a Interferon，Interferon Alpha 2b，Interferon Alpha A，Interferon Alpha 2a，Interferon Alpha-A，IFN-AlphaA，IFNA2A，INFA2，IFNA
최고 연구 개발 단계	Approved

영어 이름	Interferon alpha-2
표적 별명	IFNA2B，IFNA2C，LeIF A，Interferon alpha-2，IFN-alpha-2，IFNA2，Interferon Alpha 2，Alpha-2a Interferon，Interferon Alpha 2b，Interferon Alpha A，Interferon Alpha 2a，Interferon Alpha-A，IFN-AlphaA，IFNA2A，INFA2，IFNA
시판 약물 수	1
임상 약물 수	10
최고 연구 개발 단계	Approved

IFN-alpha 2b 제품 목록

속성
Protein (2)
제품 라이브러리
온라인 (2)
종
Human (2)
태그
Fc Tag (1)His Tag & Avi Tag (1)
마커
Unconjugated (1)Biotin-labeled (1)

제품 번호	종	발현 시스템	제품 설명	단백질 구조	순도	특성
IFB-H5253	Human	HEK293	Human IFN-alpha 2b Protein, Fc Tag (MALS verified)
IFB-H82E3	Human	HEK293	Biotinylated Human IFN-alpha 2b Protein, His,Avitag™ (MALS verified)

총 수량2

IFN-alpha 2b분자 배경

IFN-alpha is a cytokine that has an immunomodulatory function. It plays an important role not only in antiviral activity but also in several physiologic functions, such as activation of dendritic cells and accelerated expression of major histocompatibility complex I and II molecules that may cause increased antigen presentation. Variants of human leukocyte interferon alpha 2 (IFN-alpha 2a, alpha 2b, and alpha 2c) differ from each other by changes in their coding regions at nucleotide positions 137 and 170. IFN-alpha 2b (IFNα-2b) is an important cytokine and used for antiviral and anticancer treatment.

IFN-alpha 2b분자 별명

IFN-alpha 2b,IFNA2B,IFN-alpha 2 (alpha 2b),interferon alpha 2b

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Autologous CD34+-enriched hematopoietic stem and progenitor cells (Genenta Science)		Phase 2 Clinical	Genenta Science Srl	Carcinoma, Renal Cell; Glioblastoma; Multiple Myeloma	상세
NG-641	EnAd-FAP-BiTE; EnAd-FAP-Tac; NG-641; NG-aFAP	Phase 1 Clinical	Akamis Bio Ltd	Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Squamous Cell Carcinoma of Head and Neck	상세
recombinant human serum albumin-interferon-alpha-2a fusion protein (Qilu Pharmaceutical)		Phase 1 Clinical	Qilu Pharmaceutical Co Ltd	Hepatitis B	상세
Q101-pegylated interferon alfa-2a (CSPC Zhongqi Pharmaceutical Technology)		Phase 1 Clinical	CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd	Hepatitis B, Chronic	상세
PEGylated interferon alpha-1b (Shanghai Institute of Biological Products)		Phase 1 Clinical	Shanghai Institute of Biological Products Co Ltd	Hepatitis B; Neoplasms; Varicella Zoster Virus Infection	상세
SFR-1882	SFR-1882	Phase 1 Clinical	Tianjin Sinobiotech Ltd	Anemia; Renal Insufficiency	상세
CX-801	CX-801	Phase 1 Clinical	Cytomx Therapeutics Inc	Carcinoma, Renal Cell; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck	상세
ORB-011	ORB-011	Phase 1 Clinical		Neoplasms; Solid tumours	상세
interferon alfa-2b follow-on biologic (Amoytop)		Clinical	Xiamen Amoytop Biotech Co Ltd	Condylomata Acuminata; Hepatitis B; Hepatitis C; Leukemia, Hairy Cell; Lymphoma, Follicular; Melanoma; Sarcoma, Kaposi	상세
interferon-alpha2b (The University Health Network)		Clinical	University Health Network (Uhn)	Coronavirus Disease 2019 (COVID-19)	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Nadofaragene firadenovec	SCH-721015; FE-999326; SCH-209702/SCH-721015; SCH-721015/SCH-209702; TR-002	Approved	Fkd Therapies, Schering-Plough Labo Nv	Instiladrin, Adstiladrin	United States	Urinary Bladder Neoplasms	Ferring Pharmaceuticals A/S	2022-12-16	Adenocarcinoma; Carcinoma, Transitional Cell; Mesothelioma; Pancreatic Neoplasms; Solid tumours; Urinary Bladder Neoplasms	상세